HLB bioStep Co.,Ltd. (KOSDAQ:278650)

HLB bioStep Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	32,027	46,174	68,799	14,873	6,158	8,040
Short-Term Investments	-	686.98	1,578	55,000	-	2,550
Trading Asset Securities	-	-	-	27,191	4,235	4,320
Cash & Short-Term Investments	32,027	46,861	70,377	97,064	10,393	14,910
Cash Growth	-20.73%	-33.41%	-27.49%	833.97%	-30.30%	-7.98%
Accounts Receivable	7,526	7,483	3,730	7,009	7,788	6,800
Other Receivables	472.64	1,035	337.14	2,738	662.43	580.36
Receivables	8,380	8,900	4,469	10,065	10,153	8,829
Inventory	1,546	1,511	1,551	1,650	2,920	2,341
Prepaid Expenses	428.85	132.68	249	133.97	10.39	8.75
Other Current Assets	8,830	5,073	2,767	512.37	5,520	2,490
Total Current Assets	51,213	62,478	79,413	109,426	28,996	28,579
Property, Plant & Equipment	51,335	52,094	40,678	39,626	39,867	26,226
Long-Term Investments	39,173	37,687	44,916	12,811	15,051	12,287
Goodwill	6,490	6,490	1,049	1,049	1,253	1,253
Other Intangible Assets	3,144	3,485	750.69	811.65	722.08	643.24
Long-Term Deferred Tax Assets	3,121	3,100	1,096	2,127	1,302	912.09
Other Long-Term Assets	2,517	2,274	2,841	6,316	7,414	3,495
Total Assets	157,713	168,329	171,714	172,187	94,626	74,215
Accounts Payable	1,727	1,904	1,573	2,050	1,648	1,356
Accrued Expenses	543.85	675.07	438.93	533.51	324.38	282.67
Short-Term Debt	4,970	28,644	54,316	1,689	1,189	210
Current Portion of Long-Term Debt	3,748	3,748	3,448	3,224	3,000	3,000
Current Portion of Leases	369.22	414.96	367.28	398.72	841.66	696.08
Current Income Taxes Payable	-	3.11	19.77	352.86	1,444	674.94
Other Current Liabilities	11,059	10,896	4,518	4,527	8,134	9,159
Total Current Liabilities	22,417	46,285	64,682	12,775	16,582	15,379
Long-Term Debt	20,511	1,569	2,017	85,911	10,690	2,690
Long-Term Leases	280.75	320.38	487.93	418.11	583	910.01
Other Long-Term Liabilities	1,997	1,800	643.61	753.88	151.03	28.07
Total Liabilities	46,852	51,515	68,141	99,984	28,265	19,191
Common Stock	8,701	8,673	7,863	7,053	765.19	761.94
Additional Paid-In Capital	85,952	84,861	60,104	31,827	29,661	28,608
Retained Earnings	17,529	23,265	30,727	31,366	34,476	24,585
Treasury Stock	-7,332	-7,332	-1,422	-	-	-960.15
Comprehensive Income & Other	1,556	2,407	4,318	30.94	-315.38	648.22
Total Common Equity	106,406	111,874	101,590	70,278	64,587	53,643
Minority Interest	4,455	4,940	1,983	1,925	1,774	1,381
Shareholders' Equity	110,861	116,814	103,573	72,202	66,361	55,024
Total Liabilities & Equity	157,713	168,329	171,714	172,187	94,626	74,215
Total Debt	29,879	34,696	60,637	91,641	16,304	7,506
Net Cash (Debt)	2,148	12,165	9,740	5,424	-5,911	7,404
Net Cash Growth	-55.20%	24.90%	79.57%	-	-	-20.64%
Net Cash Per Share	23.97	141.83	126.96	77.48	-84.46	107.21
Filing Date Shares Outstanding	84.47	84.2	78.13	70.53	68.87	67.93
Total Common Shares Outstanding	84.47	84.2	78.13	70.53	68.87	68.57
Working Capital	28,796	16,193	14,731	96,651	12,414	13,200
Book Value Per Share	1259.68	1328.74	1300.35	996.42	937.86	782.27
Tangible Book Value	96,772	101,899	99,790	68,417	62,612	51,747
Tangible Book Value Per Share	1145.63	1210.27	1277.31	970.03	909.17	754.61
Land	27,576	27,576	15,253	15,253	13,417	9,744
Buildings	31,005	30,985	24,974	24,280	23,327	12,312
Construction In Progress	70	40	989.4	-	511.28	2,631

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.